These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9207618)

  • 1. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation.
    Mohler ER; Sorensen LC; Ghali JK; Schocken DD; Willis PW; Bowers JA; Cropp AB; Pressler ML
    J Am Coll Cardiol; 1997 Jul; 30(1):35-41. PubMed ID: 9207618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of amlodipine on serum level of some cytokines in patients with congestive heart failure].
    Salomon P; Halawa B; Karolko B
    Pol Arch Med Wewn; 2003 Feb; 109(2):149-55. PubMed ID: 12879778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure.
    Kubota T; Miyagishima M; Alvarez RJ; Kormos R; Rosenblum WD; Demetris AJ; Semigran MJ; Dec GW; Holubkov R; McTiernan CF; Mann DL; Feldman AM; McNamara DM
    J Heart Lung Transplant; 2000 Sep; 19(9):819-24. PubMed ID: 11008069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure.
    Pan JP; Liu TY; Chiang SC; Lin YK; Chou CY; Chan WL; Lai ST
    J Chin Med Assoc; 2004 May; 67(5):222-8. PubMed ID: 15357108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials.
    Dibbs Z; Thornby J; White BG; Mann DL
    J Am Coll Cardiol; 1999 Jun; 33(7):1935-42. PubMed ID: 10362196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure.
    Goldsmith SR
    Am Heart J; 1997 Jul; 134(1):13-9. PubMed ID: 9266778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
    Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
    J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
    Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM
    Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study.
    Kumar A; Singh RB; Saxena M; Niaz MA; Josh SR; Chattopadhyay P; Mechirova V; Pella D; Fedacko J
    Acta Cardiol; 2007 Aug; 62(4):349-54. PubMed ID: 17824295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators in chronic heart failure in North India.
    Fedacko J; Singh RB; Gupta A; Hristova K; Toda E; Kumar A; Saxena M; Baby A; Singh R; Toru T; Wilson DW
    Acta Cardiol; 2014 Aug; 69(4):391-8. PubMed ID: 25181914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.
    Wijeysundera HC; Hansen MS; Stanton E; Cropp AS; Hall C; Dhalla NS; Ghali J; Rouleau JL;
    Am Heart J; 2003 Aug; 146(2):291-7. PubMed ID: 12891198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Oral H; Fisher SG; Fay WP; Singh SN; Fletcher RD; Morady F
    Am J Cardiol; 1999 Feb; 83(3):388-91. PubMed ID: 10072229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation.
    O'Connor CM; Carson PE; Miller AB; Pressler ML; Belkin RN; Neuberg GW; Frid DJ; Cropp AB; Anderson S; Wertheimer JH; DeMets DL
    Am J Cardiol; 1998 Oct; 82(7):881-7. PubMed ID: 9781971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation.
    Katz SD; Rao R; Berman JW; Schwarz M; Demopoulos L; Bijou R; LeJemtel TH
    Circulation; 1994 Jul; 90(1):12-6. PubMed ID: 8025986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Int J Cardiol; 2003 Jan; 87(1):83-90. PubMed ID: 12468058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.
    Fogari R; Preti P; Zoppi A; Lazzari P; Corradi L; Fogari E; Ciccarelli L; Derosa G
    Eur J Clin Pharmacol; 2006 Oct; 62(10):817-22. PubMed ID: 16896785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).
    Mozaffarian D; Nye R; Levy WC
    J Am Coll Cardiol; 2003 Jun; 41(11):1933-9. PubMed ID: 12798560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).
    Packer M; Carson P; Elkayam U; Konstam MA; Moe G; O'Connor C; Rouleau JL; Schocken D; Anderson SA; DeMets DL;
    JACC Heart Fail; 2013 Aug; 1(4):308-314. PubMed ID: 24621933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).
    Torre-Amione G; Kapadia S; Benedict C; Oral H; Young JB; Mann DL
    J Am Coll Cardiol; 1996 Apr; 27(5):1201-6. PubMed ID: 8609343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.